Literature DB >> 2185300

The lung in patients with cirrhosis.

A G Agustí1, J Roca, J Bosch, R Rodriguez-Roisin.   

Abstract

To summarize, nowadays it seems clear that in patients with cirrhosis: (a) the pulmonary circulation is usually markedly dilated. (b) This vasodilation is due to a loss of vascular tone and it is characterized by a poor (or even absent) vascular reactivity in front of the hypoxic stimulus. (c) This abnormal behaviour of the pulmonary circulation results in VA/Q mismatching (basically perfusion of low VA/Q units) independently of airway disease, and may lower arterial PO2. (d) In the most severe cases, shunt (and perhaps O2 diffusion limitation) is becoming progressively more important. (e) The high cardiac output and minute ventilation of these patients minimize or prevent the appearance of arterial hypoxemia at rest. (f) The fall in arterial PO2 during exercise is not due to a deterioration of the degree of VA/Q mismatching seen at rest nor to any limitation in the diffusion of oxygen. It is caused by the relative 'normalization' (with respect to the metabolic demands) of the haemodynamic and ventilatory status of the patient. This may not apply to patients with severe resting arterial hypoxemia in whom the mechanisms modulating pulmonary gas exchange during exercise have not yet been addressed. What remains to be elucidated at the present time? (a) Which is (are) the precise biochemical mediator(s) of this low pulmonary vascular tone and, presumably, failure of hypoxic pulmonary vasoconstriction? It might be either a substance(s) that the failing liver fails to produce or detoxify. Thus, the ultimate biochemical basis of these physiological abnormalities must still necessarily remain speculative while awaiting future studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2185300     DOI: 10.1016/0168-8278(90)90061-u

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  [Hepatopulmonary syndrome].

Authors:  G P Glattki; C Maurer; N Satake; R Lange; K Metz; M Wettstein; U Costabel
Journal:  Med Klin (Munich)       Date:  1999-09-15

3.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

4.  Reversibility of hepatopulmonary syndrome evidenced by serial pulmonary perfusion scan.

Authors:  H Shijo; H Sasaki; H Sakata; H Kusuhara; T Ueki; M Okumura
Journal:  Gastroenterol Jpn       Date:  1993-02

5.  Hemodynamics in the immediate post-transplantation period in alcoholic and viral cirrhosis.

Authors:  Waleed K Al-Hamoudi; Saleh Alqahtani; Puneeta Tandon; Mang Ma; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

6.  CT findings in unilateral hepatopulmonary syndrome after the Fontan operation.

Authors:  Young Hun Choi; Whal Lee; Jung-Eun Cheon; Woo Sun Kim; In-One Kim; Jae Hyung Park; Kyung Mo Yeon
Journal:  Pediatr Radiol       Date:  2009-02-03

Review 7.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

8.  Arterial hypoxaemia in cirrhosis: fact or fiction?

Authors:  S Møller; J Hillingsø; E Christensen; J H Henriksen
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

9.  The relationship between severity of liver cirrhosis and pulmonary function tests.

Authors:  Irem Pembegul Yigit; Suleyman Savas Hacievliyagil; Yuksel Seckin; Ramazan Ilyas Oner; Melih Karincaoglu
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

10.  Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.

Authors:  Siciliani Luisa; Giovanna Vitale; Anna Rita Sorbo; Pompili Maurizio; Rapaccini Gian Lodovico
Journal:  J Ultrasound       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.